3,136€
-2,24%
Echtzeit-Aktienkurs Bico Group
Bid:
Ask:
Echtzeit-Chart der Bico Group Aktie
Börsenkurse Bico Group
| gettex | - | - | - | - | 3,158€ | -2,95% |
| Lang & Schwarz | - | - | - | - | 3,153€ | -3,10% |
| Tradegate | - | - | - | - | 3,153€ | -3,28% |
| Börse Stuttgart | - | - | - | - | 3,136€ | -2,24% |
| Echtzeit Euro | - | - | - | - | 3,153€ | -1,78% |
| Schwed. Kronen Indikation | - | - | - | - | 36,479SEK | -2,57% |
| Börse Frankfurt | - | - | - | - | 3,158€ | -1,62% |
Fundamentaldaten der Bico Group Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2023 [SEK] | 2,25 Mrd. | -1,68 Mrd. | -1,94 Mrd. | -27,49 | - | - | 0,10 |
| 2022 [SEK] | 2,24 Mrd. | -753,10 Mio. | -832,90 Mio. | -12,94 | - | - | 0,10 |
| 2021 [SEK] | 1,26 Mrd. | -213,40 Mio. | -193,90 Mio. | -3,39 | - | - | 0,15 |
| 2020 [SEK] | 416,01 Mio. | -54,22 Mio. | -48,17 Mio. | -1,10 | - | - | 0,39 |
| 2019 [SEK] | 105,46 Mio. | 0,05 Mio. | 0,58 Mio. | 0,02 | - | 184,47 | 1,16 |
| 2018 [SEK] | 45,34 Mio. | 1,07 Mio. | 1,18 Mio. | 0,04 | - | 82,53 | 2,30 |
| 2017 [SEK] | 13,19 Mio. | 0,14 Mio. | 0,16 Mio. | 0,01 | - | 627,20 | 6,89 |
| 2016 [SEK] | 3,62 Mio. | -0,85 Mio. | -0,85 Mio. | -0,03 | - | - | 23,91 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Bico Group Aktie
BICO Group AB engages in the provision of technologies, products, and services to create, understand, and master biology. It operates through the following segments: Bioprinting, Biosciences, Bioautomation, and Group. The Bioprinting segment includes 3D bioprinters and bioinks with a wide range of technologies for different demanding applications, resolutions, and volume and speed requirements, as well as services focused on accelerating drug discovery and development with advanced tissue imaging and cell culture services. The Biosciences segment focuses on supplying advanced lab instrumentation and smart workflow connectivity software to analyze data from applications in cell culture, cell imaging, cell sorting, and sample preparation for different analytics such as genomics. The Bioautomation segment offers scientific instruments and solutions for scalable manufacturing of diagnostics, as well as consumables to enable single-cell and other workflows. The Group segment is involved in